Capstone Investment Advisors
ALPN icon

Capstone Investment Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Capstone Investment Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,212
Closed -$1.51M – 2568
2024
Q1 		$1.51M Buy
38,212
+12,923
+51% +$381K 0.01% 914
2023
Q4 		$482K Buy
+25,289
New +$351K ﹤0.01% 1357

Capstone Investment Advisors's ALPN Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 38,212 shares — an estimated $1.51M sold.

Capstone Investment Advisors first reported a position in ALPN in Q4 2023 and held it in 2 quarters. The position peaked at $1.51M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Capstone Investment Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 38,212 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.51M.
  • Capstone Investment Advisors first reported a position in Alpine Immune Sciences Inc in Q4 2023 and held it in 2 quarters.
  • Capstone Investment Advisors's Alpine Immune Sciences Inc position peaked at $1.51M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.